Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
Beatrice Polini, Chiara Cervetto, Sara Carpi, et al.
Life (2020) Vol. 10, Iss. 12, pp. 333-333
Open Access | Times Cited: 19

Showing 19 citing articles:

Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 7
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol
Gemma Navarro, Ángel González, Adrià Sánchez-Morales, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 9354-9364
Open Access | Times Cited: 36
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 440-440
Open Access | Times Cited: 24
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
Francesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9918-9938
Open Access | Times Cited: 22
Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile
Rebecca Ferrisi, Beatrice Polini, Anna Maria Smolyakova, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation
Michał Graczyk, Agata Anna Lewandowska, Tomasz Dzierżanowski
Molecules (2021) Vol. 26, Iss. 15, pp. 4551-4551
Open Access | Times Cited: 24
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Mendhi Henna Dasram, Roderick B. Walker, Sandile M. Khamanga
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13223-13223
Open Access | Times Cited: 16
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 15
Reactive Astrocytosis in a Mouse Model of Chronic Polyamine Catabolism Activation
Chiara Cervetto, Monica Averna, Laura Vergani, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1274-1274
Open Access | Times Cited: 19
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)
Rebecca Ferrisi, Francesca Gado, Beatrice Polini, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 13
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases
Rebecca Ferrisi, Costanza Ceni, Simone Bertini, et al.
Pharmacological Research (2021) Vol. 170, pp. 105607-105607
Open Access | Times Cited: 16
Neuronal alarmin IL-1α evokes astrocyte-mediated protective signals: Effectiveness in chemotherapy-induced neuropathic pain
Lorenzo Di Cesare Mannelli, Laura Micheli, Chiara Cervetto, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105716-105716
Open Access | Times Cited: 12
N-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R)
Francesca Intranuovo, María Majellaro, Francesco Mastropasqua, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11003-11023
Closed Access | Times Cited: 2
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease
Rebecca Ferrisi, Francesca Gado, Caterina Ricardi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7201-7201
Open Access | Times Cited: 5
The cannabinoid CB 2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Journal of Receptors and Signal Transduction (2024), pp. 1-9
Closed Access | Times Cited: 1
Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits
Anthony S. Ferranti, Daniel J. Foster
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
Carmine Marco Morgillo, Antonio Lupia, Alessandro Deplano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15502-15502
Open Access | Times Cited: 4
Interplay Between Endocannabinoid System and Neurodegeneration: Focus on Polypharmacology
Francesca Seghetti, Silvia Gobbi, Federica Belluti, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 28, pp. 4796-4830
Open Access | Times Cited: 5
Cannabinoid receptor subtype 2 (CB2R): Features and targets for medical applications
Marialessandra Contino, Carmen Abate, Nicola Antonio Colabufo, et al.
Elsevier eBooks (2023), pp. 319-333
Closed Access | Times Cited: 1
Page 1

Scroll to top